Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.39 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.38 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.37 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9512238 | 0.89 | PPARG (0.42) | PPARGALDH1A1KDM4EGAAMAPT | |
| SCHEMBL9512243 | 0.89 | PPARG (0.42) | PPARGALDH1A1KDM4EGAAMAPT | |
| SCHEMBL7466596 | 0.89 | MAPT (0.45) | CA2CA12CA3CA6CA9 | |
| SCHEMBL22244209 | 0.88 | CYP3A4 (0.38) | CA2CA12CA3CA6CA9 | |
| SCHEMBL6243535 | 0.82 | MAPT (0.44) | ALDH1A1MEN1GAAMAPTKMT2A | |
| SCHEMBL5058946 | 0.81 | KMT2A (0.54) | CYP2A6ALDH1A1CYP19A1KDM4EMEN1 | |
| SCHEMBL5776081 | 0.80 | L3MBTL1 (0.43) | CA2CA12CA3CA6CA9 | |
| Hydrochloric Acid SCHEMBL8038931 | 0.79 | MAPT (0.43) | ALDH1A1KDM4EMEN1GAAMAPT | |
| SCHEMBL3100616 | 0.79 | MAPT (0.39) | CA2CA12CA9CA14ALDH1A1 | |
| SCHEMBL151232 | 0.79 | CYP2A6 (0.48) | CA2CA12CA3CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9371460-B2 | Photopolymerization method, ink set, ink composition, and water-soluble biimidazole | FUJIFILM CORPORATION (JP) | 2016-06-21 | — | — | US | disclosed |
| US-9371460-B2 | Photopolymerization method, ink set, ink composition, and water-soluble biimidazole | FUJIFILM CORPORATION (JP) | 2016-06-21 | — | — | US | disclosed |
| EP-2899241-A1 | PHOTOPOLYMERIZATION METHOD, INK SET, IMAGE FORMATION METHOD, INK COMPOSITION, AND PHOTOPOLYMERIZATION INITIATOR AND WATER-SOLUBLE BIIMIDAZOLE USED THEREIN | FUJI-FILM Corporation (JP) | 2015-07-29 | — | — | EP | disclosed |
| US-20150148442-A1 | PHOTOPOLYMERIZATION METHOD, INK SET, INK COMPOSITION, AND WATER-SOLUBLE BIIMIDAZOLE | FUJIFILM CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20150148442-A1 | PHOTOPOLYMERIZATION METHOD, INK SET, INK COMPOSITION, AND WATER-SOLUBLE BIIMIDAZOLE | FUJIFILM CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148442-A1 | PHOTOPOLYMERIZATION METHOD, INK SET, INK COMPOSITION, AND WATER-SOLUBLE BIIMIDAZOLE | JAK1, SETDB1, CCNI | CA2 4094/4885CA12 4238/4885CA3 3825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.